Detroit、MIにおける大腸癌の臨床試験
Detroitとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
被験者募集中
- Henry Ford, Detroit
Family Communications After Genetic Testing
被験者募集中健康なボランティア歓迎
- Henry Ford Health Saint John Hospital, Detroit
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
被験者募集中第2相
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
被験者募集中第3相
- Henry Ford Hospital, Detroit
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
被験者募集中第3相
- Henry Ford Hospital, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
被験者募集中第1相
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
被験者募集中第1相
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
被験者募集中第1/2相
- GSK Investigational Site, Detroit
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- Henry Ford Hospital, Detroit
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
被験者募集中第3相
- Clinical Study Site, Detroit
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Karmanos Cancer Institute, Detroit
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Investigative Site #120, Detroit
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- Henry Ford Health System, Detroit
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
被験者募集中第2相
- Karmanos Cancer Center, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
被験者募集中
- Karmanos Cancer Institute, Detroit
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
被験者募集中第1相
- Karmanos Cancer Institute, Detroit
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
被験者募集中第1相
- Henry Ford Health System, Detroit
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
被験者募集中第3相健康なボランティア歓迎
- Henry Ford Health Saint John Hospital, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- Karmanos Cancer Institute, Detroit
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
被験者募集中第1相
- Henry Ford Cancer-Detroit, Detroit
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
被験者募集中第1相
- Henry Ford Cancer Institute, Detroit
A Beta-only IL-2 ImmunoTherapY Study
被験者募集中第1/2相
- Karmanos Cancer Institute, Detroit
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
Detroitにおける他の研究
- 非小細胞肺癌44件の研究
- 乳がん33件の研究
- がん（全種類）29件の研究
- 卵巣がん26件の研究
- 転移性癌24件の研究
- 前立腺がん22件の研究
- 子宮内膜がん21件の研究
- 肺がん20件の研究
- 多発性骨髄腫19件の研究
- 胃癌16件の研究
- 頭頸部扁平上皮癌15件の研究
- 急性骨髄性白血病14件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。